|
|
BIBLIOTECA VIRTUAL
|
|
|
| |
| Documentos puestos en mayo 2012 |
| |
|
|
| A clinical trial to maintain glycemic control in youth with type 2 diabetes (2012) |
| Exercise therapy in type 2 diabetes (2012) |
| Metabolic syndrome in central Brazil: Prevalence and correlates in the adult population (2012) |
| The skin function: A factor of anti-metabolic syndrome (2012) |
| Vascular memory: Can we broaden the concept of the metabolic memory? (2012) |
| |
| Documentos puestos en abril 2012 |
| |
|
|
| Management of hyperglycemia in type 2 diabetes: A patient-centered approach (2012) |
| New insights into mechanisms of hypertension (2012) |
| Towards understanding the inherited susceptibility for nephropathy in diabetes (2012) |
| Measurement of insulin resistance in chronic kidney disease (2011) |
| Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus (2011) |
| |
| Documentos puestos en marzo 2012 |
| |
|
|
| Effectiveness of a diet and physical activity promotion strategy on the prevention of obesity in Mexican school (2012) |
| Síndrome metabólico en España: Prevalencia y riesgo coronario asociado a la definición armonizada y a la propuesta por la OMS. Estudios DARIOS (2012) |
| The extent to which adiposity markers explain the association between sedentary behavior and cardiometabolic risk factors (2012) |
| Childhood obesity: Are we all speaking the same language (2011) |
| The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat (2011) |
| Metabolic syndrome in Mexican adults. Results from the national health and nutrition survey 2006 (2010) |
| |
| Documentos puestos en febrero 2012 |
| |
|
|
| Diabetes, its treatment, and catastrophic medical spending in 35 developing countries (2012) |
| Glycated hemoglobin and associated risk factors in older adults (2012) |
| The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 DM (2012) |
| Update in the CNS response to hypoglycemia (2012) |
| |
| Documentos puestos en enero 2012 |
| |
|
|
| Diagnosis and classification of diabetes mellitus (2012) |
| Executive summary: Standards of medical care in diabetes (2012) |
| Standards of medical care in diabetes (2012) |
| Cardiometabolic risk variables in overweight and obese children: A worldwide comparison (2011) |
| Elevated fasting insulin predicts the future incidence of metabolic syndrome: A 5 year follow up study (2011) |
| |
| Documentos puestos en diciembre 2011 |
| |
|
|
| 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) (2011) |
| A two year randomized trial of obesity treatment in primary care practice (2011) |
| Intensive diabetes therapy and glomerular filtration rate type 1 diabetes (2011) |
| Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Focus on incretins (2011) |
| |
| Documentos puestos en noviembre 2011 |
| |
|
|
| ADA - Diagnosis and Classification of Diabetes Mellitus (2011) |
| Atherosclerosis (2011) |
| Pharmacokinetics of Metformin during pregnancy (2010) |
| Hypertension - The clinical management of primary hypertension in adults (2011) |
| High-Density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders (2010) |
| Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly (2011) |
| Effects of metformin on early pregnancy loss in the polycystic ovary syndrome (2002) |
| Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction (2011) |
| Adipokines in inflammation and metabolic disease (2011) |
| Treating diabetes with bariatric surgery (2009) |
| ESC/EAS Guidelines for the management of dyslipidaemias: Addenda (2011) |
| Mody - History, genetics, pathophysiology and clinical decision marking (2011) |
| NORMA oficial Mexicana NOM-008-SSA3-2010, para el tratamiento integral del sobrepeso y la obesidad |
| Metabolic syndrome: Nature, therapeutic solutions and options (2011) |
| IDF - President´s statement on who recommendation on HbA1c for diabetes diagnosis |
| Consenso ALAD - Prevención, diagnóstico y tratamiento temprano de la Nefropatía diabética |
| Nutrition support in critical illness - Bridging the evidence gap (2011) |
| Insulin therapy in renal disease (2011) |
| |
| Documentos puestos en octubre 2011 |
| |
|
|
| Control glucémico en pacientes ambulatorios con diabetes en la consulta externa del Hospital General de México (2010) |
| Relación triglicéridos/Colesterol-HDL elevada y resistencia a la insulina (2011) |
| Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance (2011) |
| Función endocrina en la obesidad (2011) |
| Retinopatía diabética; conceptos actuales (2010) |
| Implicaciones fisiopatológicas entre inflamación crónica y el desarrollo de diabetes y obesidad (2011) |
| Pathophysiological implications between chronic inflammation and the development of diabetes and obesity (2011) |
| |
| Documentos puestos en septiembre 2011 |
| |
|
|
| Ensanut 2006 |
| Noncomunicable diseases country (2011) |
| Postprandial Glucose: Maker or Risk Factor? (2011) |
| World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) - Part 1 - |
| World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) - Part 2 - |
| World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) - Part 3 - |
| World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2011) - Part 4 - |
| |
| Documentos puestos en julio 2011 |
| |
|
|
| Current status of agressive blood glucose and blood pressure control in diabetic hypertensive subjects (2011) |
| Type 2 diabetes mellitus-current therapies and the emergence of surgical options (2011) |
| Metformin: Taking away the candy for cancer? (2010) |
| Nuevas guías del American Association of Clinical Endocrinologists (2011) |
| Olmesartan Medoxomil in children and adolescents with hypertension (2010) |
| Long-Term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes (2009) |
| The product of fasting glucose and triglycerides as surrogate for identifyng insulin resistance an apparently healthy subjects (2008) |
| |
| Documentos puestos en junio 2011 |
| |
| Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries (2007) |
| New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy (2003) |
| Are oxidative stress-Actived signaling pathways mediators of insulin resistance and B-Cell dysfunction (2003) |
| Statin Therapy and risk of developing type 2 Diabetes: A meta-analysis (2009) |
| Sustained Hyperglycemia Among Patients with Diabetes (2009) |
| |
| Documentos puestos en abril 2011 |
| |
| Metformin restores impaired HDL-mediated cholesterol efflux due to glycation (2009) |
| La hipertensión arterial primaria en edades tempranas de la vida, un reto a los servicios de salud (2009) |
| Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? (2004) |
| Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes (2009) |
| |
| Documentos puestos en marzo 2011 |
| |
| The role of advanced glycation end products in progression and complications of diabetes (2008) |
| The role of "metabolic memory" in the natural history of diabetes mellitus (2009) |
| The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes (2008) |
| Fixed-dose single tablet antidiabetic combinations (2008) |
| Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (2010) |
| |
| Documentos puestos en febrero 2011 |
| |
| Diet, nutrition and the prevention of hypertension and cardiovascular diseases |
| Hypothesis: The 'metabolic memory', the new challenge of diabetes (2007) |
| Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran (2009) |
| Part 5: Adult basic life support: 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care (2010) |
| Dabigatran versus warfarin in patients with atrial fibrillation |
| |
| Documentos puestos en enero 2011 |
| |
| Diabetes and vascular disease (2007) |
| Effect of insulin resistance, dyslipidemia and Intra-abdominal Adiposity on th development of cardiovascular disease and DM (2007) |
| Adipocyte stress: The endoplasmic reticulum and metabolic disease (2007) |
| How hyperglycemia promotes atherosclerosis: molecular mechanisms (2002) |
| Inflammation and activated innate immunity in the pathogenosis of type 2 diabetes (2004) |
| |
| Documentos puestos en mayo 2010 |
| |
| Documento de posición ALAD |
| |
| Documentos puestos en abril 2010 |
| |
| Recomendaciones de la Asociación Latinoamericana de Diabetes (ALAD) sobre la salud bucal, diabetes y enfermedad cardiovascular (2009) |
| Guías ALAD “Diagnostico, control, prevención y tratamiento del Síndrome Metabólico en Pediatría (2009) |
| Evaluación en pacientes con diabetes tipo 1 del nivel alexitimia y su asociación con el grado de control metabólico (2008) |
| Consenso de Prediabetes (2009) |
| |
| Documentos puestos en marzo 2010 |
| |
| Titulo Poster por el día de la diabetes OPS-ALAD |
| Guías ALAD de diagnostico, control y tratamiento de la Diabetes Mellitus Tipo 2 |
| Synchorony edit (2009) |
| Tejido adiposo como diana terapéutica en la obesidad (2009) |
| |
| Documentos puestos en febrero 2010 |
| |
| Proteinura, Chronic Kidney Disease, and Effect of an Angiotensin-Converting Enzyme Inhibitor in Pacients with Moderate to Severe Heart Failure (2009) |
| An AT1 –Receptor- Independent Treatment Strategy for Patients with Metabolic Syndrome? (2009) |
| Chronic Treatment with Losartan Results in Sufficient Serum Levels of the Metabolite EXP3179 for PPARy Activation (2009) |
| Combination therapy of statins and fibrates in the management of cardiovascular risk (2009) |
| |
| Documentos puestos en enero 2010 |
| |
| Extented-Release Niacin (Nicotinic Acid)/Laropirant (2009) |
| Beneficio con reducciones de LDL (2009) |
| Sunset for Statins after AURORA? (2009) |
| Antioxidant Anti-Inflammatory Treatment (2009) |
| DEFINE study (2009) |
| Cordaptive deal (2009) |
| |
| Documentos puestos en 2009 |
| |
| Cognition dysfunction (2007) |
| Sleep Apnea (2007) |
| Resistence: central and peripheral mechanisms (2007) |
| Chellenges in obesity (2007) |
| Evolution of Obesity (2007) |
| Prevalencia del Síndrome Metabólico entre adultos mexicanos (enero-marzo 2008) |
| Obesity, insuline resistance (March 2008) |
| Neurobiology of the metabolic syndrome: An allostatic perspective (2008) |
| Patient-oriented and epidemiological research (2009) |
| Rosavastatin and Cardiovascular Events in Patients undergoing Hemodialysis (2009) |
| Intrauterine growth restriction and adult disease: the role of adipocytokines (2009) |
| Home Study (2009) |
Incross Study (2009)
|
| PCR and ECV en Jupiter (2009) |
| PCR Jupiter Edit 2 (2009) |
| PCR Jupiter Edit (2009) |
| Glucose Control in the ICU-How tight is too tight? (2009) |
| Intensive Versus conventional Glucose control in critically ill patients (2009) |
| |
| |
| |
|
|
|
